secwatch / observer
8-K filed June 15, 2022, 7:59 PM ET ticker ENVB CIK 0000890821
leadership confidence high sentiment neutral materiality 0.40

Enveric Biosciences appoints Mike Webb and Bevin O'Neil to board

Enveric Biosciences, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bevin O'Neil

Director
ENVB · Enveric Biosciences, Inc.
Effective
2022-06-13
Filed
June 15, 2022, 7:59 PM ET
On June 13, 2022, Mike Webb and Bevin O’Neil were appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc.
Appointed

Mike Webb

Director
ENVB · Enveric Biosciences, Inc.
Effective
2022-06-13
Filed
June 15, 2022, 7:59 PM ET
On June 13, 2022, Mike Webb and Bevin O’Neil were appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bevin O'Neil was appointed as Director at Enveric Biosciences, Inc..

Action
appointed
Role
Director
Exact text from the filing
On June 13, 2022, Mike Webb and Bevin O’Neil were appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Mike Webb was appointed as Director at Enveric Biosciences, Inc..

Action
appointed
Role
Director
Exact text from the filing
On June 13, 2022, Mike Webb and Bevin O’Neil were appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc.
View on SEC.gov

Enveric Biosciences, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-22-016803
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.